Biotechnology

Catalent commits to ADCs by upping its stake in Redwood

News from Interphex 2014

Catalent commits to ADCs by upping its stake in Redwood

By Dan Stanton

Catalent has increased its stake in Redwood Biosciences telling us it is committed to the development of antibody-drug conjugates (ADCs) and the SMARTag technology platform.

Sanofi to sell Paris R&D park

Sanofi to sell Paris R&D park

Sanofi has agreed to sell a life sciences park it owns on in Paris, France to public investment group, Caisse de Depots (CDC).

BioPharma News Vital says MIT prof

Keeping Up With The News Vital For BioPharmas Says MIT Prof

By Gareth Macdonald

Knowing about manufacturing innovations as soon as possible is more important for BioPharmas than for their small molecule counterparts according to an MIT Professor interviewed by our new sister site BioPharma-Reporter.com

AB Technology Buys Angel's Edinburgh Assets

AB Technology Buys Angel's Edinburgh Assets

By Dan Stanton

As the dissolution of Angel continues, its core manufacturing facility has been bought by AB Technology ensuring long term operations and rescuing 23 jobs.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers